<abstract xmlns="http://www.w3.org/1999/xhtml"><p>Non-cardiogenic pulmonary oedema can be life threatening and requires prompt treatment. While gadolinium-based contrast is generally considered safe with a low risk of severe side effects, non-cardiogenic pulmonary oedema has become increasingly recognised as a rare, but possibly life-threatening complication. We present a case of a usually well, young 23-year-old female who developed non-cardiogenic pulmonary oedema with a moderate oxygenation impairment and no mucosal or cutaneous features of anaphylaxis following the administration of gadolinium-based contrast. She did not respond to treatment of anaphylaxis but made a rapid recovery following the commencement of positive pressure ventilation. Our case highlights the importance of recognising the rare complication of non-cardiogenic pulmonary oedema following gadolinium-based contrast administration in order to promptly implement the appropriate treatment.</p></abstract>

Non-cardiogenic pulmonary oedema can be life threatening and requires prompt treatment. While gadolinium-based contrast is generally considered safe with a low risk of severe side effects, non-cardiogenic pulmonary oedema has become increasingly recognised as a rare, but possibly life-threatening complication. We present a case of a usually well, young 23-year-old female who developed non-cardiogenic pulmonary oedema with a moderate oxygenation impairment and no mucosal or cutaneous features of anaphylaxis following the administration of gadolinium-based contrast. She did not respond to treatment of anaphylaxis but made a rapid recovery following the commencement of positive pressure ventilation. Our case highlights the importance of recognising the rare complication of non-cardiogenic pulmonary oedema following gadolinium-based contrast administration in order to promptly implement the appropriate treatment.

Non-Cardiogenic Pulmonary Oedema Following the Use of Gadolinium-Based Contrast Medium: A Case Report

The Journal of Critical Care Medicine

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Non-cardiogenic pulmonary oedema can be life threatening and requires prompt treatment. While gadolinium-based contrast is generally considered safe with a low...

Non-Cardiogenic Pulmonary Oedema Following the Use of Gadolinium-Based Contrast Medium: A Case Report

Article Category: Case Report

Online veröffentlicht: 11. Aug. 2020

Seitenbereich: 181 - 185

Eingereicht: 09. Feb. 2020

Akzeptiert: 21. Apr. 2020

DOI: https://doi.org/10.2478/jccm-2020-0019

Schlüsselwörter
gadolinium, gadobutrol, magnetic resonance imaging, contrast, pulmonary oedema

© 2020 Chilan Nguyen, Tho Pham, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Fig. 1

Non-Cardiogenic Pulmonary Oedema Following the Use of Gadolinium-Based Contrast Medium: A Case Report

Article Category: Case Report

Online veröffentlicht: 11. Aug. 2020

Seitenbereich: 181 - 185

Eingereicht: 09. Feb. 2020

Akzeptiert: 21. Apr. 2020

DOI: https://doi.org/10.2478/jccm-2020-0019

Schlüsselwörtergadolinium, gadobutrol, magnetic resonance imaging, contrast, pulmonary oedema

© 2020 Chilan Nguyen, Tho Pham, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Fig. 1

Schlüsselwörter
gadolinium, gadobutrol, magnetic resonance imaging, contrast, pulmonary oedema